期刊文献+

表达2型单纯疱疹病毒糖蛋白D的重组痘苗病毒对动物的免疫效果 被引量:1

Studies on Immune Response to Recombinant Vaccinia Virus Expressing Herpes Simplex Virus Type 2 Glycoprotein D In Mice
原文传递
导出
摘要 用表达2型单纯疱疹病毒(HSV-2)糖蛋白D的重组痘苗病毒(R-gD-V)免疫CBA小鼠,通过间接免疫荧光(IF)(观察小鼠抗体滴度变化)和四甲基偶氮唑蓝法(MTT)动态观察细胞毒性T细胞活性(CTL),均见增高并检测了其产生的抗体对动物的保护作用。同时对R-gD-V和2型单纯疱疹病毒(HSV-2)产生的二次CTL活性进行了比较,结果表明,R-gD-V产生抗体3周达高峰(1:640),7周下降为1:320,抗体对病毒攻击动物有保护作用,其中和指数(N)为63。R-gD-V在鼠体内产生初次CTL8d达高峰,12d后消失;二次CTL持续8周之久,且CTL活性明显高于初次。R-gD-V和HSV-2相比较产生CTL在统计学上有差异(P<0.05)。说明R-gD-V能引起体液免疫和细胞免疫,对动物有保护作用。 CBA mice were immunized with recombinant vaccinia virus expressing herpes simplex virus typeⅡGlycoprotein D (R-gD-V).With indirect fluorescence and Thiaxolyl blue tetraxoliu, bromide (MTT) method, we observed iccreased antibody titer, cytotoxic T lymphocyte activities and protective ability of antibody on mice , the secondary in vitro cytotoxic Tlymphocyte(CTL)activities of R-gD-V and herpes simplexvirus typeⅡ(HSV-2).The result showed that antibody titer of R-gD-V reached its peak (1:60)in the 3st week affter immunization.The antibody showed a protective ability on mice challenged with GSV-2 .The neutralixing antibody index was 63. Primary CTL reached its peak on the 8th day and disappeared on the 12th day. The seconclary CTL remained a leval higher than primary CTL for 8weeks. There was a statistically significant difference between the CTL induced by R-gD-V and HSV-2(P<0.05).Taken together R-gD-Vinduced cellualar and humaral immunities could protect the mice challenged with tacked by GSV-2.
出处 《中华实验和临床病毒学杂志》 CSCD 1995年第3期246-249,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 疱疹病毒 痘苗病毒 疫苗 免疫 病毒蛋白 糖蛋白 Recombinant vaccinia virus MTT method Cytotoxic T lymphocyte Neutralized antibody index .
  • 相关文献

同被引文献6

  • 1中华人民共和国卫生部 联合国艾滋病中国专题组.中国艾滋病防治联合评估报告[R].北京:中华人民共和国卫生部,2003.8-10. 被引量:11
  • 2Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: WHO, 1988. 2-3. 被引量:1
  • 3Feery BJ. Adverse reactions after smallpox vaccination. Med J Aust, 1977, 2: 180-183. 被引量:1
  • 4Gomez CE, Rodriguez D, Rodriguez JR, et al. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector. Vaccine, 2002, 20: 961-997. 被引量:1
  • 5Egan MA, Pavlat WA, Tartaglia J, et al. Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte responses in seronegative adults by a non-replicating, host-range-restricted canarypox vector(ALVAC) carrying the HIV-1 MN env gene. J Infect Dis, 1995, 171:1623-1627. 被引量:1
  • 6薛绍礼,皮国华,谷淑燕,李平.表达Epstein-Barr病毒壳抗原gp125重组痘苗病毒的免疫原性[J].中国药理学通报,1999,15(3):263-265. 被引量:2

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部